Metraipolis › archive › dc_c40e3dcbc098

Biosynthesized Silver Selenide Nanoparticles from Meyerozyma guilliermondii as a Novel Adjuvant to Revolutionize Gentamicin Therapy — Europe PMC PMID:41471862

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41471862
DOI
10.3390/microorganisms13122657
License (as archived)
solo-consultazione
Archived
2026-11-08T08:11:17.648Z
SHA-256 of the archived text
18d30ccc22b83451adf21c451393d3de0f9c8c723e5b831daa280b8242ffd529
Stable URL of this page
https://metraipolis.com/documento/dc_c40e3dcbc098

How to cite

Biosynthesized Silver Selenide Nanoparticles from Meyerozyma guilliermondii as a Novel Adjuvant to Revolutionize Gentamicin Therapy — Europe PMC PMID:41471862 — Europe PMC (en), https://europepmc.org/article/MED/41471862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c40e3dcbc098 (Metraipolis archive dc_c40e3dcbc098, sha256 18d30ccc22b83451adf21c451393d3de0f9c8c723e5b831daa280b8242ffd529)
BibTeX
@misc{dcc40e3dcbc098,
  title = {Biosynthesized Silver Selenide Nanoparticles from Meyerozyma guilliermondii as a Novel Adjuvant to Revolutionize Gentamicin Therapy — Europe PMC PMID:41471862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41471862},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c40e3dcbc098; sha256 18d30ccc22b83451adf21c451393d3de0f9c8c723e5b831daa280b8242ffd529},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471862. Agents can read the archived copy with the MCP tool read_document.